Ronghai Bo
Amgen (United States) · 12 works · 464 citations · h-index 8
Top works
- Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
- Pathogen discovery from human tissue by sequence-based computational subtraction
- Identification and characterization of a novel activating mutation of the FLT3 tyrosine kinase in AML
- Genomic screen for QTLs underlying alcohol consumption in the P and NP rat lines
- IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
- An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer
- Epidemiologic study of the C-3 epimer of 25-hydroxyvitamin D3 in a population-based sample
- Identification of Quantitative Trait Loci Influencing Alcohol Consumption in the High Alcohol Drinking and Low Alcohol Drinking Rat Lines
- Mapping of QTL Influencing Saccharin Consumption in the Selectively Bred Alcohol-Preferring and -Nonpreferring Rat Lines
- Erratum to “Pathogen discovery from human tissue by sequence-based computational subtraction”
- An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer.